Andrés Vilella Weisz
Direktor/Vorstandsmitglied bei Alxerion Biotech Corp.
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Javier Pedreno | M | - |
Alxerion Biotech Corp.
 Alxerion Biotech Corp. Miscellaneous Commercial ServicesCommercial Services Alxerion Biotech Corp. engages in research and development in biotechnology. It provides services to drug delivery and discovery projects by integrating capabilities in Exosome-HTS technologies, in-house screening compounds libraries, animal models, gene therapy and nanocarrier technologies. The company was founded by Mercedes Balcells, Edelman R. Elazer and Javier Pedreño in 2017 and is headquartered in Cambridge, MA. | 7 Jahre |
| Elazer Edelman | M | 67 |
Alxerion Biotech Corp.
Alxerion Biotech Corp. Miscellaneous Commercial ServicesCommercial Services Alxerion Biotech Corp. engages in research and development in biotechnology. It provides services to drug delivery and discovery projects by integrating capabilities in Exosome-HTS technologies, in-house screening compounds libraries, animal models, gene therapy and nanocarrier technologies. The company was founded by Mercedes Balcells, Edelman R. Elazer and Javier Pedreño in 2017 and is headquartered in Cambridge, MA. | - |
| Ignacio Plaza | M | - |
Alxerion Biotech Corp.
Alxerion Biotech Corp. Miscellaneous Commercial ServicesCommercial Services Alxerion Biotech Corp. engages in research and development in biotechnology. It provides services to drug delivery and discovery projects by integrating capabilities in Exosome-HTS technologies, in-house screening compounds libraries, animal models, gene therapy and nanocarrier technologies. The company was founded by Mercedes Balcells, Edelman R. Elazer and Javier Pedreño in 2017 and is headquartered in Cambridge, MA. | - |
| Steven A. Hite | M | - |
Alxerion Biotech Corp.
Alxerion Biotech Corp. Miscellaneous Commercial ServicesCommercial Services Alxerion Biotech Corp. engages in research and development in biotechnology. It provides services to drug delivery and discovery projects by integrating capabilities in Exosome-HTS technologies, in-house screening compounds libraries, animal models, gene therapy and nanocarrier technologies. The company was founded by Mercedes Balcells, Edelman R. Elazer and Javier Pedreño in 2017 and is headquartered in Cambridge, MA. | - |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 4 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Andrés Vilella Weisz
- Persönliches Netzwerk
